Papers
1
Total Citations
4
H-Index
1
About
Shane Scott is a leading thoracic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques for lung cancer, particularly in the context of modern immunotherapy. His most notable contribution, detailed in a 2025 multicenter study, demonstrates the feasibility and safety of minimally invasive resection for non–small cell lung cancer following chemoimmunotherapy—a rapidly evolving treatment paradigm. This work, conducted across academic hospitals and already garnering 4 citations, addresses a critical gap in surgical oncology by showing that patients can undergo less invasive procedures even after potent systemic therapy, potentially reducing recovery times and complications. Scott’s research bridges the gap between cutting-edge medical oncology and surgical innovation, offering a roadmap for integrating immunotherapy with precision surgery. His findings are particularly impactful for clinicians navigating the complexities of multimodal lung cancer care. By focusing on real-world outcomes in academic settings, Scott provides evidence that challenges traditional surgical timelines, positioning him as a key voice in the shift toward personalized, minimally invasive thoracic oncology.
Research Focus
Key Achievements
Top Papers
- 1